Woodline Partners LP reduced its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 20.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,176 shares of the company's stock after selling 16,460 shares during the period. Woodline Partners LP owned about 0.35% of Addus HomeCare worth $8,044,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Squarepoint Ops LLC acquired a new position in Addus HomeCare during the 4th quarter worth approximately $389,000. Polar Capital Holdings Plc boosted its stake in Addus HomeCare by 0.6% during the 4th quarter. Polar Capital Holdings Plc now owns 29,349 shares of the company's stock worth $3,679,000 after purchasing an additional 185 shares during the period. ProShare Advisors LLC boosted its stake in Addus HomeCare by 44.4% during the 4th quarter. ProShare Advisors LLC now owns 5,263 shares of the company's stock worth $660,000 after purchasing an additional 1,619 shares during the period. Man Group plc boosted its stake in Addus HomeCare by 1.7% during the 4th quarter. Man Group plc now owns 63,537 shares of the company's stock worth $7,964,000 after purchasing an additional 1,062 shares during the period. Finally, Nuveen Asset Management LLC boosted its stake in Addus HomeCare by 0.4% during the 4th quarter. Nuveen Asset Management LLC now owns 152,459 shares of the company's stock worth $19,111,000 after purchasing an additional 559 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Stock Performance
Addus HomeCare stock traded down $1.20 during trading hours on Wednesday, reaching $114.44. 47,768 shares of the stock were exchanged, compared to its average volume of 205,659. The stock has a market cap of $2.11 billion, a P/E ratio of 26.19, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72. The firm's 50 day moving average is $103.20 and its 200 day moving average is $113.00.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare's quarterly revenue was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.21 EPS. Equities research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
ADUS has been the subject of a number of recent research reports. Macquarie increased their price target on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, JMP Securities reiterated a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $142.57.
Check Out Our Latest Analysis on Addus HomeCare
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
